11 October 2024
11 October 2024
IntelliSep is reportedly the only US Food and Drug Administration (FDA)-cleared cellular host diagnostic for use in emergency departments.
lllumina’s MiSeq i100 is a redesign of its former NGS system from 2011.
The device is designed to quickly detect non-convulsive seizures and status epilepticus in acute care settings.
The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).
CancerVision achieved 100% concordance compared to Illumina’s widely used TSO500 assay, detecting 498 variants in 49 patients.
The grant from the body’s National Heart, Lung, and Blood Institute will be used to advance trials of the device designed to continuously measure user blood pressure.
EMG needles are a vital tool in neurology, offering insights into the health of muscles and the nerves that control them.
LumiVy OsteoVy PEKK Lumbar IBF is the second device in the company’s OsteoFab product range to receive FDA approval.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
